buthionine sulfoximine has been researched along with Schizophrenia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilska-Wilkosz, A; Chwatko, G; Górny, M; Iciek, M; Kajta, M; Kamińska, A; Kamińska, K; Lorenc-Koci, E; Rogóż, Z; Wnuk, A | 1 |
| Dépré, M; Gisquet-Verrier, P; Preissmann, D; Schenk, F | 1 |
| Bertholet, L; Cabungcal, JH; Preissmann, D; Schenk, F; Sierro, G | 1 |
| Castagné, V; Cuénod, M; Do, KQ | 1 |
| Castagné, V; Cuenod, M; Do, KQ; Rougemont, M | 1 |
| Cuénod, M; Do, KQ; Neijt, HC; Steullet, P | 1 |
| Cuénod, M; Do, KQ; Guidi, R; Gysin, R; Kraftsik, R; Lavoie, S; Steullet, P | 1 |
7 other study(ies) available for buthionine sulfoximine and Schizophrenia
| Article | Year |
|---|---|
Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats.
Topics: Amino Acids, Sulfur; Animals; Buthionine Sulfoximine; Disease Models, Animal; DNA Methylation; Glutathione; Homeostasis; Male; Piperazines; Rats; Rats, Sprague-Dawley; Schizophrenia | 2019 |
Anxiety modulates cognitive deficits in a perinatal glutathione deficit animal model of schizophrenia.
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Buthionine Sulfoximine; Cognitive Dysfunction; Disease Models, Animal; Glutathione; Locomotion; Male; Prepulse Inhibition; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia; Schizophrenic Psychology | 2016 |
Accurate performance of a rat model of schizophrenia in the water maze depends on visual cue availability and stability: a distortion in cognitive mapping abilities?
Topics: Animals; Buthionine Sulfoximine; Cognition; Cues; Disease Models, Animal; Drug Administration Schedule; Female; Male; Maze Learning; Photic Stimulation; Psychomotor Performance; Rats; Rats, Mutant Strains; Rats, Wistar; Schizophrenia; Schizophrenic Psychology; Space Perception | 2011 |
An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development.
Topics: Aging; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Brain Chemistry; Buthionine Sulfoximine; Cognition Disorders; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Embryonic and Fetal Development; Enzyme Inhibitors; Exploratory Behavior; Female; Glutathione; Lipid Peroxidation; Male; Maze Learning; Medulla Oblongata; Motor Activity; Pharmacy and Therapeutics Committee; Piperazines; Pons; Pregnancy; Psychomotor Performance; Rats; Rats, Mutant Strains; Recognition, Psychology; Schizophrenia; Sex Characteristics; Time Factors | 2004 |
Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia.
Topics: Animals; Ascorbic Acid Deficiency; Body Weight; Brain; Brain Chemistry; Buthionine Sulfoximine; Cognition Disorders; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Female; Glutathione; Male; Maze Learning; Membrane Proteins; Nerve Tissue Proteins; Neurons; Oxidative Stress; Piperazines; Rats; Rats, Mutant Strains; Rats, Wistar; Recognition, Psychology; Schizophrenia; Synaptic Transmission | 2004 |
Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia.
Topics: Animals; Antimetabolites; Buthionine Sulfoximine; Electric Stimulation; Electrophysiology; Excitatory Postsynaptic Potentials; Glutamate-Cysteine Ligase; Glutathione; In Vitro Techniques; Long-Term Potentiation; Membrane Potentials; Neuronal Plasticity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synapses; Synaptic Transmission | 2006 |
A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.
Topics: Animals; Blotting, Western; Buthionine Sulfoximine; Calcium Channels, L-Type; Dopamine; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glutathione; Mice; N-Methylaspartate; Neurons; Receptors, Dopamine D2; Ryanodine Receptor Calcium Release Channel; Schizophrenia | 2008 |